Amedisys statement on cy 2023 home health final rule

Baton rouge, la., nov. 01, 2022 (globe newswire) -- amedisys, inc. (nasdaq: amed), a leading provider of quality home health, hospice, personal care and high-acuity care, issued the following statement following the cy 2023 home health final rule by the centers for medicare and medicaid services (cms).

AMED Ratings Summary

AMED Quant Ranking